Inherent Suppression of Thyroid Stimulating Hormone in Newly Diagnosed Dyslipidemic Patients – Indication for Use of Thyromimetics?

Background: Dyslipidemia triggers a sequel of metabolic derangements such as insulin resistance, hyperglycemia and oxidative stress via vicious cycle. Dyslipidemia is characterised by elevation of plasma cholesterol, triglycerides (TGs), or both, or a low level of high-density lipoprotein (HDL) whic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Diagn Res
Autors principals: Udupa, Sridevi V., D’Souza, Vivian, Udupa, Vinit A., Manjrekar, Poornima A.
Format: Artigo
Idioma:Inglês
Publicat: JCDR Research and Publications (P) Limited 2014
Matèries:
Biochemistry Section
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225880/
https://ncbi.nlm.nih.gov/pubmed/25386428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2014/10363.4905
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars